Valeda

If you or a family member has dry AMD, there is now a new FDA-approved option available. Valeda® is designed to slow disease progression, preserve vision, and help protect your eyesight—especially in the earlier stages of the condition.

Wagner Kapoor Institute is the first in several states in our region to offer Valeda®, a light-based, non-invasive treatment for dry age-related macular degeneration (AMD).

Our specialists are here to help you understand your options and determine if Valeda® is right for you.

Valeda® Light Delivery System

Valeda is the first and only FDA-authorized treatment for dry age-related macular degeneration (AMD) to improve vision.

Valeda photobiomodulation (PBM) treatment is non-invasive and targets disease at the cellular level. Valeda delivers select wavelengths of light that act on cellular mechanisms important to dry AMD and enhance mitochondrial function to improve cellular energy (ATP) production.

Unlike high-power lasers used for surgery, Valeda PBM involves low-intensity light that does not cause heat or damage, making it a safe and effective treatment option for ocular diseases such as dry AMD.

Valeda PBM has applications and is being studied across various fields, including dermatology, neurology, and ophthalmology, for conditions such as wound healing, neurodegenerative diseases, and macular degeneration.

Learn more today!

Call: 757-481-4000